Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.865
-0.075 (-3.87%)
Dec 3, 2024, 1:59 PM EST - Market open
Standard BioTools Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 155.9 | 106.34 | 97.95 | 128.85 | 131.39 | 116.69 | Upgrade
|
| Other Revenue | - | - | - | 1.73 | 6.76 | 0.55 | Upgrade
|
| Revenue | 155.9 | 106.34 | 97.95 | 130.58 | 138.14 | 117.24 | Upgrade
|
| Revenue Growth (YoY) | 48.23% | 8.57% | -24.99% | -5.47% | 17.83% | 3.79% | Upgrade
|
| Cost of Revenue | 80.19 | 55.89 | 53 | 99.15 | 91.28 | 84.6 | Upgrade
|
| Gross Profit | 75.71 | 50.45 | 44.95 | 31.43 | 46.87 | 32.64 | Upgrade
|
| Selling, General & Admin | 140.37 | 87.54 | 102.29 | 98.89 | 97.9 | 84.48 | Upgrade
|
| Research & Development | 55.27 | 25.95 | 33.86 | - | - | - | Upgrade
|
| Operating Expenses | 195.64 | 113.49 | 136.14 | 98.89 | 97.9 | 84.48 | Upgrade
|
| Operating Income | -119.93 | -63.04 | -91.19 | -67.46 | -51.04 | -51.84 | Upgrade
|
| Interest Expense | -4.57 | -4.57 | -4.33 | -3.82 | -3.57 | -4.28 | Upgrade
|
| Interest & Investment Income | 12.9 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.68 | 0.48 | -62.53 | 7.62 | 0.51 | 1.43 | Upgrade
|
| EBT Excluding Unusual Items | -112.27 | -67.13 | -158.05 | -63.66 | -54.1 | -54.69 | Upgrade
|
| Merger & Restructuring Charges | -37.39 | -7.08 | -9.73 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -11.43 | - | - | - | Upgrade
|
| Other Unusual Items | 25.21 | - | -13.72 | - | - | -12.02 | Upgrade
|
| Pretax Income | -124.45 | -74.2 | -192.93 | -63.66 | -54.1 | -66.71 | Upgrade
|
| Income Tax Expense | 0.14 | 0.45 | -2.83 | -4.42 | -1.08 | -1.92 | Upgrade
|
| Net Income | -124.59 | -74.66 | -190.1 | -59.24 | -53.02 | -64.79 | Upgrade
|
| Net Income to Common | -170.6 | -74.66 | -190.1 | -59.24 | -53.02 | -64.79 | Upgrade
|
| Shares Outstanding (Basic) | 280 | 79 | 78 | 76 | 72 | 67 | Upgrade
|
| Shares Outstanding (Diluted) | 280 | 79 | 78 | 76 | 72 | 67 | Upgrade
|
| Shares Change (YoY) | 253.41% | 1.09% | 3.32% | 5.19% | 7.88% | 68.41% | Upgrade
|
| EPS (Basic) | -0.61 | -0.94 | -2.43 | -0.78 | -0.74 | -0.97 | Upgrade
|
| EPS (Diluted) | -0.62 | -0.94 | -2.43 | -0.78 | -0.74 | -0.97 | Upgrade
|
| Free Cash Flow | -148.51 | -46.12 | -93.2 | -57.33 | -28.13 | -37.74 | Upgrade
|
| Free Cash Flow Per Share | -0.53 | -0.58 | -1.19 | -0.76 | -0.39 | -0.57 | Upgrade
|
| Gross Margin | 48.57% | 47.44% | 45.89% | 24.07% | 33.92% | 27.84% | Upgrade
|
| Operating Margin | -76.92% | -59.28% | -93.10% | -51.66% | -36.94% | -44.22% | Upgrade
|
| Profit Margin | -109.43% | -70.21% | -194.08% | -45.36% | -38.38% | -55.26% | Upgrade
|
| Free Cash Flow Margin | -95.26% | -43.37% | -95.15% | -43.90% | -20.37% | -32.19% | Upgrade
|
| EBITDA | -114.31 | -59.06 | -87.69 | -63.81 | -47.02 | -47.23 | Upgrade
|
| EBITDA Margin | -73.32% | -55.54% | -89.53% | -48.86% | -34.04% | -40.29% | Upgrade
|
| D&A For EBITDA | 5.61 | 3.98 | 3.5 | 3.65 | 4.01 | 4.61 | Upgrade
|
| EBIT | -119.93 | -63.04 | -91.19 | -67.46 | -51.04 | -51.84 | Upgrade
|
| EBIT Margin | -76.92% | -59.28% | -93.10% | -51.66% | -36.94% | -44.22% | Upgrade
|
| Revenue as Reported | 155.9 | 106.34 | 97.95 | 130.58 | 138.14 | 117.24 | Upgrade
|
| Advertising Expenses | - | 2 | 3.9 | 3.4 | 1.6 | 3.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.